A Cost Comparison of Management of Chronic Hepatitis B and Its Associated Complications in Hong Kong and Singapore

Journal of Clinical Gastroenterology

Volumn 38, Issue 10, 2004, Pages S136-S143

  Li, Shu C ^a   Ong, Sien C ^a   Lim, Seng G ^b,c   Yeoh, Khay G ^c   Kwong, Kai S ^d   Lee, Vivian ^d   Lee, Winnie ^d   Lau, Joseph ^d   Wong, Ian ^e   Kung, Nelson ^b,f   Leung, Wai T ^d   Chan, Henry L Y ^d   Chan, Francis K L ^d   Sung, Joseph J Y ^d   Lee, Kenneth K C ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF LONDON   (United Kingdom)

^f UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

cost of disease; disease states; hepatitis B; management cost

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COST; ECONOMICS; HEPATITIS B; HONG KONG; HUMAN; MIDDLE AGED; RETROSPECTIVE STUDY; SINGAPORE;

ADOLESCENT; ADULT; AGED; COSTS AND COST ANALYSIS; HEPATITIS B, CHRONIC; HONG KONG; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; SINGAPORE;

MLCS; MLOWN;

EID: 21644434760     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/00004836-200411003-00004     Document Type: Article

References (18)

1. World Health Organization. Hepatitis B Fact Sheet WHO/204, Revised October 2000. Available at: http://www.who.int/inf-fs/en/fact204.html. Accessed September 20, 2003.
2. Merican I, Guan R, Amarapuka D, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000;15:1356–1361.
3. Teo EK, Fock KM. Hepatocellular carcinoma: an Asian perspective [Review]. Dig Dis. 2001;19:263–268.
4. Lok AS, Lai CL, Wu PC, et al. Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol. 1987;126:492–499.
5. Sung JJY. Epidemiology of hepatitis A in Asia and experience with the HAV vaccine in Hong Kong [Review]. J Viral Hepat. 2000;7(suppl 1): 27–28.
6. Tang KY. Hepatitis B,1997 and the Chinese community: an appraisal of their relationships. J Public Health Med. 1997;19:200–202.
7. Chia KS, Lee JJ, Wong JL, et al. Cancer incidence in Singapore, 1998 to 1999. Ann Acad Med Singapore. 2002;31:745–750.
8. State of Health Editorial Committee. Health trends. In: State of Health 2001: The Report of the Director of Medical Services. Singapore: Ministry of Health, 2002:4–23.
9. James L, Fong CW, Foong BH, et al. Hepatitis B Seroprevalence Study 1999. Singapore Med J. 2001;42:420–424.
10. Lo SK. Liver transplantation in chronic hepatitis B: a new era? Singapore Med J. 1998;39:47–48.
11. Goh KT. Prevention and control of hepatitis B virus infection in Singapore. Ann Acad Med Singapore. 1997;26:671–681.
12. Melnick JL. Hepatitis B virus and primary hepatocellular carcinoma. Prog Med Virol. 1980;26:20.
13. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer. 1988;61:1942–1956.
14. Yang BM, Paik SW, Hahn OS, et al. Economic evaluation of the societal costs of hepatitis B in South Korea. J Gastroenterol Hepatol. 2001;16: 301–308.
15. Hong Kong SAR. China. Available at: http://www.info.gov.hk. Accessed on May 23, 2003.
16. Guan R, Merican I, Amarapukar D, et al. Chronic hepatitis B infection: management practices in Asia. Med Prog. 2001;28:25–29.
17. Metcalf M, Brown N, Peterson S, et al. Health care costs associated with chronic hepatitis B. Am J Health Syst Pharm. 1999;56:232–236.
18. Yeoh KG, Chua CKY, Goh CHL. Cost burden of hepatitis B infection in Singapore. Gastroenterology. 2000;118:6784.